2007
The Role of the Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Cytokine System in Primary Hyperparathyroidism
Nakchbandi IA, Lang R, Kinder B, Insogna KL. The Role of the Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Cytokine System in Primary Hyperparathyroidism. The Journal Of Clinical Endocrinology & Metabolism 2007, 93: 967-973. PMID: 18073309, PMCID: PMC2266956, DOI: 10.1210/jc.2007-1645.Peer-Reviewed Original ResearchConceptsNuclear factor-kappaB ligandPrimary hyperparathyroidismBone lossReceptor activatorTotal femurIL-6Bone resorptionIL-6 soluble receptorMild primary hyperparathyroidismBone mineral densitySoluble receptor activatorMechanism of actionIL-6sRSRANKL levelsSerum levelsBone turnoverMineral densityCytokine systemSoluble receptorHyperparathyroidismNormal rangeSkeletal responsivenessBiochemical markersPatientsGreater risk
2004
Hypercalcemia and Hypercalcemia Treatment
Kinder B. Hypercalcemia and Hypercalcemia Treatment. 2004, 517-529. DOI: 10.1016/b0-12-475570-4/00643-0.Peer-Reviewed Original ResearchGastrointestinal calcium absorptionNormal calcium regulationRenal calcium excretionUrgent clinical problemHypercalcemia treatmentCalcium excretionRole of calciumCalcium absorptionNew bone formationBone resorptionClinical problemHypercalcemiaAppropriate managementBone formationCalcium regulationHomeostatic systemPatientsExcretionResorption
2002
Circulating Levels of Interleukin-6 Soluble Receptor Predict Rates of Bone Loss in Patients with Primary Hyperparathyroidism
Nakchbandi IA, Mitnick MA, Lang R, Gundberg C, Kinder B, Insogna K. Circulating Levels of Interleukin-6 Soluble Receptor Predict Rates of Bone Loss in Patients with Primary Hyperparathyroidism. The Journal Of Clinical Endocrinology & Metabolism 2002, 87: 4946-4951. PMID: 12414855, DOI: 10.1210/jc.2001-011814.Peer-Reviewed Original ResearchConceptsBone lossIL-6sRTotal femurIL-6IL-6 soluble receptorPrimary hyperparathyroidism resultsYearly bone lossSubset of patientsUntreated hyperparathyroidismDisease activityPrimary hyperparathyroidismUpper tertileCytokine axisHyperparathyroidismSoluble receptorPatientsBiochemical markersClassical biochemical markersWhole groupFemurPredict rateGreater rateRecent studiesTertileGroup
1998
Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease.
Tallini G, Ghossein RA, Emanuel J, Gill J, Kinder B, Dimich AB, Costa J, Robbins R, Burrow GN, Rosai J. Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease. Journal Of Clinical Oncology 1998, 16: 1158-66. PMID: 9508203, DOI: 10.1200/jco.1998.16.3.1158.Peer-Reviewed Original ResearchConceptsReverse transcription-polymerase chain reactionPeripheral bloodThyroid diseaseThyroid carcinomaBenign thyroid nodulesThyroid peroxidaseThyroid nodulesRT-PCR positivityPeripheral blood samplesDiagnosis of carcinomaTranscription-polymerase chain reactionPapillary thyroid carcinomaBenign thyroid lesionsRET/PTC1Cervical lymphInitial surgeryClinical evidenceExtrathyroid extensionNodular hyperplasiaBenign lesionsPatientsCarcinomaBlood collectionMRNA transcriptsThyroid lesions
1995
localization Studies in Patients with Hyperparathyroidism
Mitchell B, Kinder B, Merrell R. localization Studies in Patients with Hyperparathyroidism. Surgical Clinics Of North America 1995, 75: 483-498. PMID: 7747254, DOI: 10.1016/s0039-6109(16)46635-1.Peer-Reviewed Original ResearchConceptsMultiple gland diseasePrevious neck surgeryCervical explorationSuspicious glandsParathyroid explorationPersistent diseasePreoperative localizationMinimal morbiditySestamibi SPECTHigh success rateNeck surgeryInvasive proceduresGland diseaseParathyroid anatomySurgical handsPatientsSkilled surgical handsSuccess rateHyperparathyroidismComplementary testsDiseaseGlandLimited sensitivityLocalization studiesMorbidity
1988
Poorly differentiated ("insular") carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms.
Flynn S, Forman B, Stewart A, Kinder B. Poorly differentiated ("insular") carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms. Surgery 1988, 104: 963-70. PMID: 3194848.Peer-Reviewed Original ResearchConceptsTotal thyroidectomyInsular carcinomaDisease 1 yearMajority of patientsAggressive clinical courseExternal beam irradiationDifferentiated thyroid neoplasmsEntire neoplasmFocal recurrenceNode dissectionAggressive treatmentClinical courseFatal courseLocal recurrenceDistant metastasisInitial diagnosisDifferentiated carcinomaAggressive subsetTumor necrosisPapillary carcinomaSuch aggressive behaviorThyroid carcinomaInsular componentPatientsCarcinomaAdvances in the Diagnosis and Treatment of Pheochromocytoma
Havlik R, Cahow C, Kinder B. Advances in the Diagnosis and Treatment of Pheochromocytoma. JAMA Surgery 1988, 123: 626-630. PMID: 3282495, DOI: 10.1001/archsurg.1988.01400290112020.Peer-Reviewed Original ResearchConceptsPerioperative fluid requirementsTotal catecholamine levelsAlpha-adrenergic blockadeIntraoperative hemodynamic stabilityTreatment of pheochromocytomaManagement of pheochromocytomaDiagnosis of pheochromocytomaHemodynamic stabilityCatecholamine levelsCatecholamine excretionSelective blockadeFluid requirementsComputed tomographyPheochromocytomaPatientsPhenoxybenzamine hydrochlorideBiochemical diagnosisPrazosin hydrochlorideDiagnosisBlockadePhenoxybenzaminePrazosinSurgeryYearsExcretion
1980
Diagnostic and Therapeutic Approaches to Primary Hyperparathyroidism
Kinder B, Broadus A, Lang R, Rasmussen H. Diagnostic and Therapeutic Approaches to Primary Hyperparathyroidism. Surgical Clinics Of North America 1980, 60: 1285-1295. PMID: 7434165, DOI: 10.1016/s0039-6109(16)42251-6.Peer-Reviewed Original Research